Cell Sources for Cartilage Repair—Biological and Clinical Perspective
Cell-based therapy represents a promising treatment strategy for cartilage defects. Alone or in combination with scaffolds/biological signals, these strategies open many new avenues for cartilage tissue engineering. However, the choice of the optimal cell source is not that straightforward. Currentl...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2496 |
id |
doaj-098bfe7a2b79489dbd14b42893190cf7 |
---|---|
record_format |
Article |
spelling |
doaj-098bfe7a2b79489dbd14b42893190cf72021-09-25T23:53:30ZengMDPI AGCells2073-44092021-09-01102496249610.3390/cells10092496Cell Sources for Cartilage Repair—Biological and Clinical PerspectiveInga Urlić0Alan Ivković1Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Orthopaedic Surgery, University Hospital Sveti Duh, 10000 Zagreb, CroatiaCell-based therapy represents a promising treatment strategy for cartilage defects. Alone or in combination with scaffolds/biological signals, these strategies open many new avenues for cartilage tissue engineering. However, the choice of the optimal cell source is not that straightforward. Currently, various types of differentiated cells (articular and nasal chondrocytes) and stem cells (mesenchymal stem cells, induced pluripotent stem cells) are being researched to objectively assess their merits and disadvantages with respect to the ability to repair damaged articular cartilage. In this paper, we focus on the different cell types used in cartilage treatment, first from a biological scientist’s perspective and then from a clinician’s standpoint. We compare and analyze the advantages and disadvantages of these cell types and offer a potential outlook for future research and clinical application.https://www.mdpi.com/2073-4409/10/9/2496cartilage repairchondrocytesstem cellsarticular cartilageautologous chondrocyte transplantationregenerative medicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Inga Urlić Alan Ivković |
spellingShingle |
Inga Urlić Alan Ivković Cell Sources for Cartilage Repair—Biological and Clinical Perspective Cells cartilage repair chondrocytes stem cells articular cartilage autologous chondrocyte transplantation regenerative medicine |
author_facet |
Inga Urlić Alan Ivković |
author_sort |
Inga Urlić |
title |
Cell Sources for Cartilage Repair—Biological and Clinical Perspective |
title_short |
Cell Sources for Cartilage Repair—Biological and Clinical Perspective |
title_full |
Cell Sources for Cartilage Repair—Biological and Clinical Perspective |
title_fullStr |
Cell Sources for Cartilage Repair—Biological and Clinical Perspective |
title_full_unstemmed |
Cell Sources for Cartilage Repair—Biological and Clinical Perspective |
title_sort |
cell sources for cartilage repair—biological and clinical perspective |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2021-09-01 |
description |
Cell-based therapy represents a promising treatment strategy for cartilage defects. Alone or in combination with scaffolds/biological signals, these strategies open many new avenues for cartilage tissue engineering. However, the choice of the optimal cell source is not that straightforward. Currently, various types of differentiated cells (articular and nasal chondrocytes) and stem cells (mesenchymal stem cells, induced pluripotent stem cells) are being researched to objectively assess their merits and disadvantages with respect to the ability to repair damaged articular cartilage. In this paper, we focus on the different cell types used in cartilage treatment, first from a biological scientist’s perspective and then from a clinician’s standpoint. We compare and analyze the advantages and disadvantages of these cell types and offer a potential outlook for future research and clinical application. |
topic |
cartilage repair chondrocytes stem cells articular cartilage autologous chondrocyte transplantation regenerative medicine |
url |
https://www.mdpi.com/2073-4409/10/9/2496 |
work_keys_str_mv |
AT ingaurlic cellsourcesforcartilagerepairbiologicalandclinicalperspective AT alanivkovic cellsourcesforcartilagerepairbiologicalandclinicalperspective |
_version_ |
1717367634407718912 |